Affordable healthcare Product Selection for Opportunistic Infections IDA HIV/AIDS Group, Nienke Gruppelaar “ HIV does not kill, opportunistic infections.

Slides:



Advertisements
Similar presentations
Key1 World Bank Training Program on HIV/AIDS Drugs Training Module 3 Selection and Quantification based on the World Bank document Battling HIV/AIDS: A.
Advertisements

24th June World Health Organization Clinical Staging, AIDS surveillance and Mortality in resource-poor settings a clinicians view of strategic information.
Treatment and Prevention of Opportunistic Infections: Options for the Caribbean Region Excerpted from presentation by Jonathan E. Kaplan, M.D.
Review of HIV and Opportunistic Infections (OI) in Children
ARV Nurse Training Programme Marcus McGilvray & Nicola Willis
BORDERNETwork Training on Late Presenter Dr. med. Wolfgang Güthoff / Alexander Leffers, M.A.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 9 Antifungal and Antiviral Agents.
A 32 year old Gay man is admitted with a three month history of weight loss, fatigue, intermittent fever and lymphadenopathy. One month ago he developed.
Module 1: Overview of HIV Infection Unit 01.03: Natural History and Progression Of HIV Infection 1.
STAGING OF HIV INFECTION, COMMON AND OPPORTUNISTIC INFECTIONS
HIV 101 Review Evaluation Center for HIV and Oral Health Boston University School of Public Health Health & Disability Working Group.
Ois generalPCPCryptococcus-Toxoplasma
The HIV virus. Committee on Oversight and Government Reform. HIV/AIDS Today, 1(1):1, January 18, 2008.
P AUL A LLYN, MD A FRICAN A MERICAN HIV U NIVERSITY U NIVERSITY OF C ALIFORNIA L OS A NGELES A UGUST 28, 2014.
Roundtable Presentation S Tripathy National AIDS Research Institute 73 G Block, MIDC Bhosari, Pune , India.
Immunodeficiencies HIV/AIDS. Immunodeficiencies Due to impaired function of one or more components of the immune or inflammatory responses. Problem may.
Diagnostic testing for HIV: The symptomatic patient.
Adapted from curriculum by Tucson Interfaith HIV/AIDS Network
HIV AND AIDS.
Medical-Surgical Nursing: An Integrated Approach, 2E Chapter 23
Late presenters and opportunistic infections Jane Bruton Clinical Research Nurse Imperial College.
Chronic HIV Infection Clinical Manifestations Opportunistic Infections O.I. Prophylaxis.
Presented By: Peer Education Training Sites Jeopardy Team 1 Team 2.
AIDS Acquired Immune Deficiency Syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the Human Immunodeficiency.
The Silent Epidemic Any pathogen that spreads from one person to another during sexual contact is called a sexually transmitted infection, or STI. More.
Do Now Make two lists: one with a list of HIV symptoms and one with a list of AIDS symptoms. Make two lists: one with a list of HIV symptoms and one with.
 Heterosexual  Bi-sexual  Homosexual Blood and Blood Products  Blood transfusion  Tissue Transplantation e.g Kidney Transmission Modes for HIV (2)
VIRUSES. Lytic vs. Lysogenic Vaccines First made was in 1700’s- fight smallpox Help prevent viral infections, but they cannot cure most viral infection.
Immunology, the HIV life cycle and stages of infection Anele Waters HIV Research Nurse North Middlesex Hospital, London.
Classification of HIV and Expanded AIDS Surveillance Case Definition.
1 Respiratory Diseases in HIV-infected Patients HAIVN Harvard Medical School AIDS Initiative in Vietnam.
PMTCT Generic Training PackageModule 1Slide 1 Introduction to HIV/AIDS M O D U L E 1.
26 YEARS OF HIV EPIDEMY 10 years HAART Dan Turner, MD, Tel-Aviv Sourasky Medical Center.
Paul Allyn, MD African American HIV University University of California Los Angeles August 26, 2015.
Complications of HIV Infection: Opportunistic Infections and Malignancies Rafael E. Campo, MD Slides courtesy of Luis A. Espinoza, MD Division of Infectious.
1 Starting ART in the Context of Opportunistic Infections HAIVN Harvard Medical School AIDS Initiative in Vietnam.
1 Overview of Opportunistic Infections in HIV/AIDS HAIVN Harvard Medical School AIDS Initiative in Vietnam.
1 County of Los Angeles Department of Public Health Division of HIV and STD Programs Jason Dawson, MPH Program Support Services
Arnold School of Public Health Health Services, Policy, and Management 1 Drug Treatment Disparities Among African Americans Living with HIV/AIDS Carleen.
Connie van Marrewijk IDA Foundation Product Selection for Opportunistic Infections.
HIV/AIDS. Human Immunodeficiency Virus  Virus attacks the immune system  Invades and destroys certain white blood cells  Takes time for the HIV to.
1 HIV Clinical Staging HAIVN Harvard Medical School AIDS Initiative in Vietnam.
FIGURE 1. URETHRAL DISCHARGE. Treatment of Urethral Discharge GonorrheaChlamydia Ciprofloxacin 500mg orally x 1 doseAzithromycin 1g orally x 1 dose Cefixime.
Introduction to the diagnosis and management of common opportunistic infections (Ols) Module 4 Sub module OIs.
Prophylaxis of Opportunistic Infections
HIV and AIDS PM2 PATHOPHYSIOLOGY. HIV is the causative agent of AIDS Human immunodeficiency virus Human immunodeficiency virus retrovirus retrovirus most.
Human Immunodeficiency Virus & Acquired Immunodeficiency Syndrome Community Medicine - Reporting October 10, 2011.
Questions, Answers, and Explanations Infectious Diseases Blueprint.
HIV D S O’Briain March Pathology of HIV Epidemic disease Influenza pandemic Legionnaire’s disease 1976 HIV 1981 Heroin, Dublin 2000 SARS.
29-1 A Human Perspective HIV Disease and Complications of Immunodeficiency Eugene Nester Denise Anderson Evans Roberts, Jr. Nancy Pearsall Martha Nester.
Starting ART in the setting of Opportunistic Infections in children
Chapter 5: The Medical Side of Living with HIV/AIDS.
Late Diagnosis of HIV in Northern Ireland Walker E, Todd SEJ, Rafferty P, Donnelly CM, Emerson CR, Dinsmore WW, Quah SP, McCarty EJ Department of Genito-Urinary.
Treatment and Prevention of Opportunistic Infections: Options for the Caribbean Region Jonathan E. Kaplan, M.D.
Chapter 2: The Path from HIV to AIDS
Slideset on: Emery S, Neuhaus JA, Phillips AN, et al. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving.
Important diseases and their global impact Objectives To be able to describe the causes and means of transmission of malaria, AIDS/HIV and T.B To be able.
Initiative taken by Health Camp
HIV / AIDS HUMAN IMMUNODEFICIENCY Virus (HIV) ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
HIV/AIDS Review.
HIV, AIDS and other STIs.
Chapter 85 HIV and AIDS.
IDA Solutions Clarisse Morris, MA January 2006
Adapted from curriculum by Tucson Interfaith HIV/AIDS Network
HIV Opportunistic infections
AIDS Dr. Amitabha Basu MD.
PCP in adults: Presentation , Treatment and Prophylaxis
PCP in adults: Presentation , Treatment and Prophylaxis
Management of Immune Reconstitution Inflammatory Syndrome (IRIS)
HIV and AIDS.
Presentation transcript:

Affordable healthcare Product Selection for Opportunistic Infections IDA HIV/AIDS Group, Nienke Gruppelaar “ HIV does not kill, opportunistic infections do!”

- 2 - Frequency of OI (US) Male(%)Female(%) Pneumocystis carinii pneumonia Kaposi sarcoma Esophageal candidiasis Wasting syndrome Mycobacterium avium complex Pulmonary tuberculosis Extrapulmonary cryptococcosis HIV encephalopathy Cytomegalovirus retinitis Cytomegalovirus disease Toxoplasmosis of brain Chronic cryptosporidiosis Recurrent pneumonia Extrapulmonary tuberculosis Chronic herpes simplex2.04.1

- 3 - Pneumocystis Carinii Pneumonia (PCP) Very common among HIV-infected people PCP almost always occurs when CD4 < 200 First choice Co-Trimoxazole oral tablets (960 mg or higher dosage), 3 times a day If CD4<200, Profylaxis Co-Trimoxazole 960 mg once a day

- 4 - Bacterial infections and Protozoal Infections TB, PCP (pneumonia),Toxoplasmosis, gastro-intestinal infections Medicines: Azithromycine * (tabs), Clarithromycine * (tabs) Ceftriaxone (tabs, injection) Cefixime (tabs) Ciprofloxacin (tabs), Ofloxacin (tabs), Levofloxacin Co-trimoxazole, (CTX) prophylaxis daily (tabs, injection) Clindamycine (caps) Tinidazole (caps), Metronidazole Pyrimethamine, Sulfadiazine*

- 5 - Effect of TB on HIV disease TB is the most frequent ‘opportunistic’ infection in HIV+ people TB is the leading cause of death in HIV+ people TB may occur at any moment in HIV disease but the risk increases as the disease progresses TB treatment: Attention to overlapping drug toxicities & drug-drug interactions

- 6 - Fungal Infections Candidiasis (oral trush), Cryptococcal Menigitis, Cryptosporidiosis Medicines: Clotrimazole (cream, vaginal tabs) Miconazole (oral tabs) AmphotericineB (injection) * Fluconazole (caps)

- 7 - Miconazole for treatment of Oral candidiasis IDA supplies a convenient once daily dosage form of Miconazole Cost-effective treatment for oral candidiasis Convenient, long-acting topical drug which can be used at lowest level of care (home based care workers)

- 8 - Viral Infections Cytomegalovirus (CMV), Herpes Zoster, Hepatitis, Herpes Simplex Medicines: Aciclovir (tabs, IV) Ganciclovir (caps, IV) * Valganciclovir (tabs) * Ganciclovir & Valganciclovir are relative expensive, and require skilled healthcare workers in high-end resource setting

- 9 - Malignancies Kaposi's sarcoma, CNS lymphoma, Non Hodgkin's lymphoma, Cervical cancer Medicines: Vincristine, Vinblastine Etoposide Doxorubicine All injections, Specialised care is needed

Other infections Diarrhoea: ORS Worm infections: Albendazole Malaria: Quinine, Artmether, Artesunate

Palliative Care Reliefing pain, improving quality of life Physical pain, Fevers, night sweats, poor sleep, weight loss –Paracetamol (tab 500mg), Codeine (tab), Ibuprofen (tab) Diclofenac (tab), Multivitamins (tabs, syrup), Diazepam (tab 5mg, injection 10mg/2ml) Physical pain (severe) –Opioids: Morphine (tabs, oral solution, injection) Psychological effects: anger, anxiety, depression, fatigue/lethargy, loss of appetite etc.

Conclusion Treatment OIs essential part of HIV/AIDS programs Effective treatment for most frequent OIs is available –Not all medicines are currently available from a generic source Total overview: Price Indicator IDA